3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Classical hematology
1
Conditions
Ovarian Neoplasms
15
Neoplasms
3
Sarcoma
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Uterine Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Endometrial Stromal
1
Sarcoma, Alveolar Soft Part
1
Rhabdomyosarcoma
1
Recurrence
1
Peritoneal Neoplasms
1
Ovarian Epithelial Cancer Recurrent
1
Ovarian Diseases
1
Neurofibrosarcoma
1
Neoplasms by Site
1
Malignant mesenchymal tumor
1
Liposarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Hemangiosarcoma
1
Hemangiopericytoma, Malignant
1
Genital Diseases, Female
1
Gastrointestinal Stromal Tumors
1
Fibrosarcoma
1
Fanconi Anemia, Complementation Group D1
1
Endocrine Gland Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinoma
1
Interventions
olaparib
5
talazoparib
1
liposomal doxorubicin
1
Trabectedin
1
Surveys and Questionnaires
1
Genetic Counseling
1
Demography
1
Data Collection
1
Counseling
1
Cognitive Behavioral Therapy
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fanconi Anemia, Complementation Group D1
×
Trabectedin
×
Gynecologic
×
Clear all
NCT01772979
2013-01-21
MITO15
Catholic University of the Sacred Heart
Phase 2
Unknown
100 enrolled